연구동향 분석

Original Article : Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus

( Hyun Young Woo ) Jong-Young Choi ( Seung Kew Yoon ) ( Dong Jin Suh ) ( Seung Woon Paik ) ( Kwang Hyub Han ) ( Soon Ho Um ) ( Byung Ik Kim ) ( Heon Ju Lee ) ( Mong Cho ) ( Chun Kyon Lee ) ( Dong Joon Kim ) ( Jae Seok Hwang ) 2014년

논문상세정보
인용/피인용
' Original Article : Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • adefovirdipivoxil
  • decompensation
  • hepatitis b virus
  • lamivudine-resistant
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,700 0

0.0%

' Original Article : Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus' 의 참고문헌

  • Virologic response and resistance to adefovir in patients with chronic hepatitis B
    Fung SK J Hepatol 44 : 283 ~ 290 - [2006]
  • Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine
    Allen MI J Clin Microbiol 37 : 3338 ~ 3347 - [1999]
  • Timing of lamivudine administration according to Child class in patients with decompensated cirrhosis
    Bae SH J Gastroenterol Hepatol 20 : 1527 ~ 1532 - [2005]
  • Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy
    van Bömmel F Hepatology 44 : 318 ~ 325 [2006]
  • Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver
    de Jongh FE Gastroenterology 103 : 1630 ~ 1635 [1992]
  • Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil
    Yeon JE Gut 55 : 1488 ~ 1495 - [2006]
  • Outcomes of patients with hepatitis B who developed antiviral resistance while on the liver transplant waiting list
    Osborn MK Clin Gastroenterol Hepatol 5 : 1454 ~ 1461 - [2007]
  • Molecular virology and the development of resistant mutants: implications for therapy
    Locarnini S. Semin Liver Dis 25 (Suppl 1) : 9 ~ 19 - [2005]
  • Low-dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus
    Perrillo R Gastroenterology 109 : 908 ~ 916 - [1995]
  • Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection
    Yao FY J Hepatol 33 : 301 ~ 307 - [2000]
  • Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B
    Villeneuve JP Hepatology 31 : 207 ~ 210 - [2000]
  • Lamivudine for patients with chronic hepatitis B and advanced liver disease
    Liaw YF N Engl J Med 351 : 1521 ~ 1531 - [2004]
  • Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy
    Lee YS Hepatology 43 : 1385 ~ 1391 - [2006]
  • Hepatitis B virus. The major etiology of hepatocellular carcinoma
    Beasley RP. Cancer 61 : 1942 ~ 1956 - [1988]
  • Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
    Lavanchy D. J Viral Hepat 11 : 97 ~ 107 - [2004]
  • Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation
    Bain VG Transplantation 62 : 1456 ~ 1462 - [1996]
  • Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group
    Liaw YF Gastroenterology 119 : 172 ~ 180 - [2000]
  • Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy
    Fontana RJ Gastroenterology 123 : 719 ~ 727 - [2002]
  • Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virus-related decompensated liver cirrhosis
    Tseng PL J Viral Hepat 12 : 386 ~ 392 - [2005]
  • Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection
    van Bömmel F Hepatology 40 : 1421 ~ 1425 [2004]
  • Chronic hepatitis B
    Lok AS Hepatology 45 : 507 ~ 539 - [2007]
  • Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis
    Kapoor D J Hepatol 33 : 308 ~ 312 - [2000]
  • Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients
    Schiff ER Hepatology 38 : 1419 ~ 1427 - [2003]
  • Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results
    Schiff E Liver Transpl 13 : 349 ~ 360 - [2007]
  • Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
    Marcellin P N Engl J Med 348 : 808 ~ 816 - [2003]
  • Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B
    Hadziyannis SJ N Engl J Med 348 : 800 ~ 807 - [2003]
  • Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B
    Peters MG Gastroenterology 126 : 91 ~ 101 - [2004]
  • Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus
    Perrillo R Gastroenterology 126 : 81 ~ 90 - [2004]
  • Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAgnegative chronic hepatitis B
    Rapti I Hepatology 45 : 307 ~ 313 - [2007]
  • A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update
    Keeffe EB Clin Gastroenterol Hepatol 4 : 936 ~ 962 - [2006]
  • A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B
    Perrillo RP Hepatology 33 : 424 ~ 432 - [2001]
  • A model to predict survival in patients with end-stage liver disease
    Kamath PS Hepatology 33 : 464 ~ 470 - [2001]
  • A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
    Malinchoc M Hepatology 31 : 864 ~ 871 [2000]